Trademark Overview
On Tuesday, November 11, 2025, a trademark application was filed for NEXTINK with the United States Patent and Trademark Office. The USPTO has given the NEXTINK trademark a serial number of 99491575. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, November 11, 2025. This trademark is owned by XIAMEN SINOPEG BIOTECH CO., LTD.. The NEXTINK trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for cellular therapy for the treatment of cancer; Diagnostic preparations for medical purposes; Chemical reagents for medical or veterinary purposes; Nutraceuticals for use as a dietary supplement; Bacterial preparations for medical and veterinary use; Chemical preparations for pharmaceutical or medical purposes, namely, for prevention or treatment of cancer, infectious diseases, and chronic diseases opotherapy preparations; Chemical preparations for pharmaceutical or medical purposes, namely, for prevention or treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
